Insmed Incorporated
INSM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $30,495 | $19,051 | $13,798 | $12,360 |
| - Cash | $335 | $1,284 | $403 | $555 |
| + Debt | $745 | $739 | $1,143 | $1,149 |
| Enterprise Value | $30,906 | $18,506 | $14,538 | $12,953 |
| Revenue | $142 | $107 | $93 | $104 |
| % Growth | 32.5% | 15.7% | -11.1% | – |
| Gross Profit | $84 | $79 | $72 | $78 |
| % Margin | 58.7% | 73.9% | 77.1% | 75% |
| EBITDA | -$344 | -$297 | -$233 | -$212 |
| % Margin | -241.9% | -276.6% | -250.8% | -202.7% |
| Net Income | -$370 | -$322 | -$257 | -$236 |
| % Margin | -260% | -299.5% | -276.4% | -225.5% |
| EPS Diluted | -1.75 | -1.7 | -1.42 | -1.32 |
| % Growth | -2.9% | -19.7% | -7.6% | – |
| Operating Cash Flow | -$220 | -$206 | -$262 | -$196 |
| Capital Expenditures | -$2 | -$3 | -$10 | -$7 |
| Free Cash Flow | -$222 | -$209 | -$272 | -$203 |